Emerging Markets Business Unit
Ricardo Marek is President of Emerging Markets Business Unit (EM BU), and a member of Takeda’s Executive Team, reporting to the Company’s CEO & President, Christophe Weber.
Ricardo has over 25 years of experience in various industries and leadership roles. Having joined Takeda in 2011, he simultaneously held the roles of Area Head for Latin America (LATAM) from 2014, and President for Brazil from 2013. Prior to that, he was Chief Financial Officer, Brazil.
During his tenure as President of EM BU, Mr. Marek has been instrumental in ensuring even greater alignment of Takeda’s diverse range of products in over 35 countries around the Companies’ chosen strategic therapy areas, re-shaped the China business for greater future success, and further strengthened leadership capabilities in key roles within his senior team. Under his stewardship as Chair of Takeda’s global Access to Medicines strategy, related approaches have resulted in program implementation that has increased the depth and breadth of positive impact on the lives of patients.
Prior to his current role, Mr. Marek led the realignment and restructuring of the LATAM Area, positioning it as one of the top performers across EM BU, and Takeda Brazil as one of the top 10 pharmaceutical companies in the country. He also secured a number of acquisitions as well as launched the Oncology business in the region for Takeda’s potentially life-saving and life-transforming medicines. Under his leadership, Takeda was recognised for the first time as a Top Employer in all seven countries across the LATAM region, and also received several other HR awards, such as Great Place to Work®.
Before joining Takeda in 2011, Mr. Marek was CFO for Organon International in the U.S., and Managing Director and Vice President Finance for the Akzo Nobel Group in Brazil. He also has experience in other industries such as chemicals and aerospace.
A Brazilian national, Ricardo holds an MBA from the University of Sao Paulo, Brazil.